“Evaluation of Serum Fibroblast Growth Factor 23 for Cardiovascular Risk Prediction in Chronic Kidney Disease Patients: A Study Using the SCORE2 Risk Model”, Int. J. Environ. Sci., vol. 11, no. 12s, pp. 1360–1367, Jun. 2025, doi: 10.64252/8crhea08.